Company
Merrimack Pharmaceuticals, Inc.
Headquarters: Cambridge, MA, United States
Founded: 2000 in Cambridge, Massachusetts
Employees: 426
CEO: Mr. Gary L. Crocker M.B.A., MBA
Market Cap
$189.8 Million
USD as of Jan. 1, 2024
Merrimack Pharmaceuticals, Inc. Categories
United States Healthcare BiotechnologyUnited States Healthcare United States Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was founded in 1993 and is headquartered in Cambridge, Massachusetts.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Merrimack Pharmaceuticals, Inc. has the following listings and related stock indices.
Stock: NASDAQ: MACK wb_incandescent
Stock: FSX: MP6N wb_incandescent
Stock: XSTU: MP6N wb_incandescent